Endometriosis Recurrence After Excision Surgery: Risk Reduction Guide Released

Lotus Endometriosis Institute has published a patient resource addressing post-surgical endometriosis recurrence, with coverage of hormonal therapy options, follow-up protocols, and staging research led by Dr. Steven Vasilev.

Arroyo Grande, United States, September 19, 2026 /PressCable/ -- Lotus Endometriosis Institute has released a patient guide that takes on one of the most common recovery concerns following endometriosis surgery: the possibility of the disease returning. Dr. Steven Vasilev leads the institute, which acknowledges surgery as a central part of treatment while making clear that even a well-performed procedure does not guarantee lasting protection against recurrence.

More information is available at https://lotusendo.com/answers/can-endometriosis-come-back-after-excision-surgery

Recurrence is a legitimate, evidence-grounded concern rather than a source of unnecessary worry, Dr. Vasilev said, since symptoms or lesions can reappear months or even years after surgery. A systematic review and meta-analysis published in Human Reproduction Update examined postoperative hormonal suppression across 14 studies involving 1,766 patients, finding a pooled relative risk of 0.41 (95% CI 0.26-0.65) for recurrence among patients receiving hormonal suppression compared with expectant management or placebo, with follow-up ranging from 12 to 36 months and a median of 18 months. That figure is why Lotus Endometriosis Institute frames recovery planning in years rather than weeks.

The institute's guide outlines a patient-friendly framework built around three pillars: continued medical therapy, a structured follow-up schedule, and prompt attention to any change in symptoms. This framing positions surgery as one phase within a longer management strategy rather than a single endpoint for recovery.

Among the strategies detailed, postoperative hormonal therapy is presented as an option supported by research, particularly for patients who are not immediately trying to conceive. The institute notes that the specific therapy chosen should reflect each patient's goals, tolerance, and reproductive plans.

Risk also varies according to disease type and surgical staging, and the guide reflects that complexity. It references the AAGL staging system, which studies suggest can help predict recurrence after ovarian endometrioma surgery, with risk differences becoming more apparent around the 36-month mark. The guide also addresses abdominal wall endometriosis, a less common recurrence pattern that has been linked to multiple prior cesarean sections.

According to the institute, recurrence prevention works best as a proactive effort rather than a reaction to worsening symptoms. Pairing precise excision surgery with an ongoing integrative recovery plan reflects the institute's broader approach of combining surgical skill with longer-term recovery support.

More information is available at https://lotusendo.com

Contact Info:
Name: Dr. Steven Vasilev
Email: Send Email
Organization: Lotus Endometriosis Institute
Address: 154 Traffic Way, Arroyo Grande, CA 93420, United States
Website: https://lotusendo.com

Source: PressCable

Release ID: 89203812

In the event of detecting errors, concerns, or irregularities in the content shared in this press release that require attention or if there is a need for a press release takedown, we kindly request that you inform us promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your feedback within 8 hours and take necessary actions to resolve any identified issues diligently or guide you through the removal process. Providing accurate and dependable information is our utmost priority.